ARTICLE | Company News
ProStrakan, Uluru, Crawford Pharmaceuticals deal
July 5, 2010 7:00 AM UTC
ProStrakan's Strakan International Ltd. subsidiary and partner Uluru will divest their interest in acne drug Zindaclin clindamycin to an undisclosed Crawford subsidiary for up to $5.1 million total. ...